Related Experiment Videos
Relationship between bisphosphonate concentration and osteoclast activity and viability
D J Rowe1, L A Etre, M J Lovdahl
1Dows Institute for Dental Research, College of Dentistry, University of Iowa, Iowa City 52242, USA.
In Vitro Cellular & Developmental Biology. Animal
|August 26, 1999
Summary
Difluoromethylidene bisphosphonate (F2MBP) rapidly enters bone and induces osteoclast apoptosis, effectively inhibiting bone resorption. This mechanism is dose- and time-dependent, highlighting F2MBP
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Bisphosphonates, including difluoromethylidene bisphosphonate (F2MBP), are known inhibitors of bone resorption.
- An analytical method using anion exchange and postcolumn indirect fluorescence detection has been developed for F2MBP quantification in bone.
Purpose of the Study:
- To correlate F2MBP concentration in embryonic bone organ cultures with its physiological effects.
- To investigate the impact of F2MBP on bone resorption and osteoclast viability.
Main Methods:
- Organ culture of embryonic bones treated with varying doses and durations of F2MBP.
- Measurement of 45Ca release to assess bone resorption.
- Microscopic evaluation of osteoclast morphology and incidence of apoptosis.
- Quantification of F2MBP in bone samples.
Main Results:
- F2MBP induced osteoclast apoptosis, characterized by nuclear fragmentation, in a dose- and time-dependent manner.
- A decrease in normal osteoclasts correlated with reduced 45Ca release, indicating inhibited bone resorption.
- Rapid F2MBP uptake was observed, with short incubation periods (5 min or 6 h) yielding effects similar to continuous 48-h exposure.
Conclusions:
- F2MBP rapidly accumulates in bone and induces osteoclast apoptosis, which is the primary mechanism for inhibiting bone resorption.
- The study establishes a relationship between intracellular F2MBP concentrations and its effects on osteoclast activity and viability.